<code id='CE49050B35'></code><style id='CE49050B35'></style>
    • <acronym id='CE49050B35'></acronym>
      <center id='CE49050B35'><center id='CE49050B35'><tfoot id='CE49050B35'></tfoot></center><abbr id='CE49050B35'><dir id='CE49050B35'><tfoot id='CE49050B35'></tfoot><noframes id='CE49050B35'>

    • <optgroup id='CE49050B35'><strike id='CE49050B35'><sup id='CE49050B35'></sup></strike><code id='CE49050B35'></code></optgroup>
        1. <b id='CE49050B35'><label id='CE49050B35'><select id='CE49050B35'><dt id='CE49050B35'><span id='CE49050B35'></span></dt></select></label></b><u id='CE49050B35'></u>
          <i id='CE49050B35'><strike id='CE49050B35'><tt id='CE49050B35'><pre id='CE49050B35'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:573

          Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

          advertisement

          For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Disappointing trial forces Pfizer to pivot on obesity medicine plans
          Disappointing trial forces Pfizer to pivot on obesity medicine plans

          MarkLennihan/APPfizeronFridaysaiditwasstoppingdevelopmentofatwice-dailyoralobesitymedicationafteranu

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          J&J to emphasize cancer drugs, stop much of its vaccine research

          DanielHulshizer/APEightmonthsintohistenure,Johnson&Johnson’sR&Dchiefisputtingabigemphasisonm